Mitsubishi Gas Chemical Co Inc (4182):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Mitsubishi Gas Chemical Co Inc (4182) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C12371
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Mitsubishi Gas Chemical Co Inc (MGC) is a chemicals company. It provides various products in a wide range of fields from basic chemicals to fine chemicals and functional materials. The company produces and sells xylene isomers, xylene derivatives and foaming plastics; inorganic chemicals and engineering plastics; methanol, amines, polyols, ammonia, methacrylates, enzymes, and crude oil; and printed circuit boards (PCB), PCB materials, and oxygen absorber. MGC serves automobiles, environment, electronics, life sciences, and energy sectors in Asia, North America, and other regions. It has manufacturing plants in Japan and R&D centers in Tokyo, Niigata, and Hiratsuka. MGC is headquartered in Tokyo, Japan.

Mitsubishi Gas Chemical Co Inc (4182) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Mitsubishi Gas Chemical Co Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Mitsubishi Gas Chemical Co Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Mitsubishi Gas Chemical Co Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Mitsubishi Gas Chemical Co Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Mitsubishi Gas Chemical Co Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Mitsubishi Gas Chemical Co Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Taiwan Sugar Enters into Partnership with Mitsubishi Gas Chemical and Cultivecs 10
Mitsubishi Gas Chemical and Nippon Kayaku Form Joint Venture 11
GlycoNex Enters Into Agreement With Mitsubishi Gas Chemical For Cancer Antibody 12
Mitsubishi Gas Chemical Co Inc – Key Competitors 13
Mitsubishi Gas Chemical Co Inc – Key Employees 14
Mitsubishi Gas Chemical Co Inc – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Joint Venture 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Mitsubishi Gas Chemical Co Inc, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Mitsubishi Gas Chemical Co Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Mitsubishi Gas Chemical Co Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Mitsubishi Gas Chemical Co Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Mitsubishi Gas Chemical Co Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Mitsubishi Gas Chemical Co Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Taiwan Sugar Enters into Partnership with Mitsubishi Gas Chemical and Cultivecs 10
Mitsubishi Gas Chemical and Nippon Kayaku Form Joint Venture 11
GlycoNex Enters Into Agreement With Mitsubishi Gas Chemical For Cancer Antibody 12
Mitsubishi Gas Chemical Co Inc, Key Competitors 13
Mitsubishi Gas Chemical Co Inc, Key Employees 14
Mitsubishi Gas Chemical Co Inc, Other Locations 15
Mitsubishi Gas Chemical Co Inc, Subsidiaries 16
Mitsubishi Gas Chemical Co Inc, Joint Venture 18

List of Figures
Mitsubishi Gas Chemical Co Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Mitsubishi Gas Chemical Co Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Mitsubishi Gas Chemical Co Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Mitsubishi Gas Chemical Co Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Mitsubishi Gas Chemical Co Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Mitsubishi Gas Chemical Co Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Mitsubishi Gas Chemical Co Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Mitsubishi Gas Chemical Co Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Mitsubishi Gas Chemical Co Inc (4182):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Moorim SP Co., Ltd.:企業の戦略・SWOT・財務情報
    Moorim SP Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Moorim SP Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Karnataka Power Corporation Ltd:企業の戦略的SWOT分析
    Karnataka Power Corporation Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Samsung Electronics Co Ltd (005930)-医療機器分野:企業M&A・提携分析
    Summary Samsung Electronics Co., Ltd. (Samsung) is a manufacturer of consumer electronics, information technology and mobile communications, and device solutions. The company’s product portfolio includes television (TV), washing machine, refrigerator, air conditioner, medical devices, monitor, print …
  • Conair Corporation
    Conair Corporation - Strategy, SWOT and Corporate Finance Report Summary Conair Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Western & Southern Financial Group, Inc.:戦略・SWOT・企業財務分析
    Western & Southern Financial Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Western & Southern Financial Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • US WorldMeds LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary US WorldMeds LLC (US WorldMeds) is a specialty pharmaceutical company that develops, licenses and markets healthcare products to improve lives of patients with challenging conditions and unmet medical needs. The company’s products comprise apokyn, myobloc and revonto. Its apokyn is used for …
  • Trinity Mirror plc:企業の戦略・SWOT・財務情報
    Trinity Mirror plc - Strategy, SWOT and Corporate Finance Report Summary Trinity Mirror plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Pavmed Inc (PAVM):企業の製品パイプライン分析2018
    Summary Pavmed Inc (Pavmed) is a medical device company. The company offers disposable infusion pumps, short-term catheters, percutaneous and tissue ablation devices, and long-term vascular access devices. Its products pipeline includes CarpX, a percutaneous device to treat carpal tunnel syndrome; P …
  • Kindred Healthcare Inc (KND):製薬・医療:M&Aディール及び事業提携情報
    Summary Kindred Healthcare Inc (Kindred Healthcare) is a healthcare services provider with focus on post-acute care services. The company through its subsidiaries offers home health, hospice and community care services to patients in homes, nursing centers, and other residential settings. It operate …
  • Zeus Co., Ltd. (079370):企業の財務・戦略的SWOT分析
    Zeus Co., Ltd. (079370) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • United Energy Group Ltd (467):企業の財務・戦略的SWOT分析
    Summary United Energy Group Ltd (UEG) is an independent upstream oil and gas company that offers exploration and production of oil and gas reserves. The company's activities include merger and acquisition of oil and natural gas assets, exploitation, development and production of crude oil and natura …
  • Mediclinic International Plc (MDC):製薬・医療:M&Aディール及び事業提携情報
    Summary Mediclinic International Plc (Mediclinic), formerly Al Noor Hospitals Group Plc is a healthcare service provider. The center offers services such as specialist-orientated, acute-care and multi disciplinary healthcare services. It also provides clinical services such as pre hospital emergency …
  • OBI Pharma Inc (4174):医療機器:M&Aディール及び事業提携情報
    Summary OBI Pharma Inc (OBI Pharma) is a biopharmaceutical company that develops therapies for the treatment of cancer and infectious diseases. The company’s products include adagloxad simolenin, an active immunotherapy which is intended for the treatment of metastatic breast cancer; and OBI-833, a …
  • 2020 GeneSystems Inc:医療機器:M&Aディール及び事業提携情報
    Summary 20/20 GeneSystems Inc (20/20 Gene) is a medical diagnostic company. The company discovers, develops, and commercializes proteomics products and diagnostic tests for therapy selection, early disease detection, and biodefense applications. It provides tests in the areas of early detection of l …
  • Duke Energy Corporation:発電所・企業SWOT分析
    Duke Energy Corporation - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key emplo …
  • Kirin Holdings Co Ltd:企業の戦略・SWOT・財務情報
    Kirin Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Kirin Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Genesis Energy, L.P.:企業の戦略・SWOT・財務分析
    Genesis Energy, L.P. - Strategy, SWOT and Corporate Finance Report Summary Genesis Energy, L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Garanti Technology:企業の戦略・SWOT・財務情報
    Garanti Technology - Strategy, SWOT and Corporate Finance Report Summary Garanti Technology - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Senseonics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Senseonics Inc (Senseonics), a subsidiary of Senseonics Holdings Inc, is a medical device company that designs, develops and commercializes of glucose monitoring products. Its products, Eversense and Eversense XL, are implantable continuous glucose monitoring (CGM) systems that help people w …
  • Grasim Industries Ltd (GRASIM):企業の財務・戦略的SWOT分析
    Grasim Industries Ltd (GRASIM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆